Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The future of patient-derived xenografts in prostate cancer research.

Autor: Lawrence MG; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. mitchell.lawrence@monash.edu.; Melbourne Urological Research Alliance, Monash Biomedicine Discovery Institute, Clayton, Victoria, Australia. mitchell.lawrence@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mitchell.lawrence@monash.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. mitchell.lawrence@monash.edu.; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia. mitchell.lawrence@monash.edu., Taylor RA; Melbourne Urological Research Alliance, Monash Biomedicine Discovery Institute, Clayton, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia.; Department of Physiology, Monash University, Clayton, Victoria, Australia., Cuffe GB; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Ang LS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Clark AK; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands., Goode DL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Porter LH; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Le Magnen C; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Urology, University Hospital Basel, Basel, Switzerland.; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Navone NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands., Wang Y; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada., van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Corey E; Department of Urology, University of Washington, Seattle, WA, USA., Isaacs JT; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pharmacology and Molecular Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Urology, University of Washington, Seattle, WA, USA., Risbridger GP; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. gail.risbridger@monash.edu.; Melbourne Urological Research Alliance, Monash Biomedicine Discovery Institute, Clayton, Victoria, Australia. gail.risbridger@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. gail.risbridger@monash.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. gail.risbridger@monash.edu.; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia. gail.risbridger@monash.edu.

Publikováno v: Nature reviews. Urology [Nat Rev Urol] 2023 Jun; Vol. 20 (6), pp. 371-384. Date of Electronic Publication: 2023 Jan 17.

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.

Autor: De Sarkar N; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Pathology and Prostate Cancer Center of Excellence, Medical College of Wisconsin, Milwaukee, Wisconsin., Patton RD; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Doebley AL; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington.; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington.; Medical Scientist Training Program, University of Washington, Seattle, Washington., Hanratty B; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Adil M; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Kreitzman AJ; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Sarthy JF; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Ko M; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Brahma S; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Meers MP; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Janssens DH; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Ang LS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Coleman IM; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Bose A; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Dumpit RF; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Lucas JM; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Nunez TA; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Nguyen HM; Department of Urology, University of Washington, Seattle, Washington., McClure HM; Dana-Farber Cancer Institute, Boston, Massachusetts., Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Brotman Baty Institute for Precision Medicine, Seattle, Washington., Schweizer MT; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington., Morrissey C; Department of Urology, University of Washington, Seattle, Washington., Choudhury AD; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Baca SC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Berchuck JE; Dana-Farber Cancer Institute, Boston, Massachusetts., Freedman ML; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ahmad K; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Montgomery RB; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington., Corey E; Department of Urology, University of Washington, Seattle, Washington., Henikoff S; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Howard Hughes Medical Institute, Chevy Chase, Maryland., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Urology, University of Washington, Seattle, Washington.; Brotman Baty Institute for Precision Medicine, Seattle, Washington.; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington., Ha G; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington.; Brotman Baty Institute for Precision Medicine, Seattle, Washington.; Department of Genome Sciences, University of Washington, Seattle, Washington.

Publikováno v: Cancer discovery [Cancer Discov] 2023 Mar 01; Vol. 13 (3), pp. 632-653.

Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.

Autor: Patel RA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Coleman I; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Roudier MP; Department of Urology, University of Washington, Seattle, WA, USA., Konnick EQ; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; The Brotman Baty Institute for Precision Medicine, Seattle, WA, USA., Hanratty B; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Dumpit R; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Lucas JM; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Ang LS; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Low JY; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Tretiakova MS; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Ha G; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; The Brotman Baty Institute for Precision Medicine, Seattle, WA, USA., Lee JK; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., True LD; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., De Marzo AM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, MD, Baltimore, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; The Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Morrissey C; Department of Urology, University of Washington, Seattle, WA, USA., Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; The Brotman Baty Institute for Precision Medicine, Seattle, WA, USA., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 May; Vol. 2 (5), pp. 277-285. Date of Electronic Publication: 2022 May 02.

Density Functional Theory Study of 12mer Single-Strand Guanine Oligomer and Associated Muon Hyperfine Interaction.

Autor: Zaharim WN; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia.; USM-RIKEN Interdisciplinary Collaboration for Advance Sciences, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia.; Meson Science Laboratory, RIKEN, Wako, Saitama 351-0198, Japan., Ahmad SNA; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia., Sulaiman S; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia.; USM-RIKEN Interdisciplinary Collaboration for Advance Sciences, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia.; Meson Science Laboratory, RIKEN, Wako, Saitama 351-0198, Japan.; Physics Section, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia., Rozak H; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia.; Meson Science Laboratory, RIKEN, Wako, Saitama 351-0198, Japan., Hasan Baseri DF; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia., Mohamad Rosli NA; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia., Mohd-Tajudin SS; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia., Ang LS; Faculty of Applied Sciences, Universiti Teknologi MARA Perlis Branch, Arau Campus, Arau, Perlis 02600, Malaysia., Watanabe I; Computational Chemistry and Physics Laboratory, School of Distance Education, Universiti Sains Malaysia, Gelugor, Pulau Pinang 11800, Malaysia.; Meson Science Laboratory, RIKEN, Wako, Saitama 351-0198, Japan.

Publikováno v: ACS omega [ACS Omega] 2021 Oct 27; Vol. 6 (44), pp. 29641-29650. Date of Electronic Publication: 2021 Oct 27 (Print Publication: 2021).